HOME >> MEDICINE >> NEWS
Bioactive cement scaffold may improve bone grafts

A new technology for implants that may improve construction or repair of bones in the face, skull and jaw, has been developed by researchers from the American Dental Association Foundation (ADAF) and the National Institute of Standards and Technology (NIST).

Described in recent and upcoming journal articles,* the new technology provides a method for making scaffolds for bone tissue. The scaffold is seeded with a patient's own cells and is formed with a cement paste made of minerals also found in natural bone. The paste is mixed with beads of a natural polymer (made from seaweed) filled with bone cells. The paste is shaped or injected into a bone cavity and then allowed to harden with the encapsulated cells dispersed throughout the structure. The natural polymer beads gradually dissolve when exposed to the body's fluids, creating a scaffold that is filled by the now released bone cells.

The cement, a calcium phosphate material, is strengthened by adding chitosan, a biopolymer extracted from crustacean shells. The implant is further reinforced to about the same strength as spongy natural bone by covering it with several layers of a biodegradable fiber mesh already used in clinical practice.

"Bone cells are very smart," says Hockin Xu, of the ADAF and principal investigator for the project. "They can tell the difference between materials that are bioactive compared to bioinert polymers. Our material is designed to be similar to mineral in bone so that cells readily attach to the scaffold." The researchers used mouse bone cells in their experiments, but in practice surgeons would use cells cultured from patient samples. In addition to creating pores in the hardened cement, the natural polymer beads protect the cells during the 30 minutes required for the cement to harden. Future experiments will develop methods for improving the material's mechanical properties by using smaller encapsulating beads that biodegrade at a predictable rate.
'"/>

Contact: Gail Porter
gail.porter@nist.gov
301-975-3392
National Institute of Standards and Technology (NIST)
14-Apr-2006


Page: 1 2

Related medicine news :

1. Nursing home placement associated with accelerated cognitive decline in Alzheimers disease
2. Reducing cardiovascular disease risk factors when discontinuing hormone replacement therapy
3. SCAI Founders Lecture highlights remarkable progress in catheter-based aortic valve replacement
4. Percutaneous aortic valve replacement safe, successful in high-risk patients
5. Fluid displacement from legs to neck can lead to obstructive sleep apnea
6. Decline in breast cancer cases likely linked to reduced use of hormone replacement
7. Greater cooperation needed for advancement of stem cell research
8. Hormone replacement therapy may improve trip down memory lane
9. Exercise prior to hip and knee replacement reduces need for inpatient rehabilitation
10. Predictors of undergoing joint replacement surgery among patients with severe osteoarthritis
11. Anti-inflammatory drugs following hip replacement surgery could harm rather than help

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Bioactive cement scaffold may improve bone grafts

(Date:5/22/2013)... Margate City, NJ (PRWEB) May 22, 2013 ... from solved. In some states, up to twenty-seven percent ... half of all bankruptcies of private citizens in the U.S. ... medical care also affects prescription drugs, meaning that many patients ... doctor, or even get them filled at all. That's ...
(Date:5/22/2013)... Beginning Aug. 22, teens are invited ... Spirit of Innovation Challenge . The annual program ... and open to students ages 13 - 18 from ... Challenge celebrates the life and entrepreneurial spirit of astronaut ... The program challenges teens to work in teams of ...
(Date:5/22/2013)... May 22, 2013 The 2013 release of ... is the largest change to hit the field of mental ... is will help prepare for the release with a Webinar ... been trained knowing no other diagnostic scheme besides the now ... manual will be released worldwide. In honor of this event, ...
(Date:5/22/2013)... May 22, 2013 Abadir Associates, a ... treatments for optimal results, is offering a new technique ... neck. The practice has successfully treated multiple patients ... “Basically, this approach is for women who want to ... dermatologist Dr. Michelle Abadir of Abadir Associates. ...
(Date:5/22/2013)... May 22 2013 - Research presented today shows ... in rats similar to those produced by drugs ... presented by addiction expert Francesco Leri, Associate Professor ... University of Guelph, suggest food addiction could explain, ... These results were presented at the 2013 ...
Breaking Medicine News(10 mins):Health News:Lyrica Discount Cards Now Available From MedicationDiscountCard.com 2Health News:Conrad Foundation Announces 2013-2014 Spirit of Innovation Challenge Launch Date 2Health News:What You Need to Know About DSM-5: The Asheville Jung Center is Hosting a Webinar Tonight on the New Material in DSM-5 2Health News:Westchester Dermatologist Abadir Associates Offers New Neck Lift Surgery Alternative 2Health News:Addiction to unhealthy foods could help explain the global obesity epidemic 2
(Date:5/22/2013)... 22, 2013   Upsher-Smith Laboratories, Inc. ... its global Phase III clinical trial for ... for the management of epilepsy in adults, ... is specifically engineered to provide convenient once-daily ... levels observed with currently available treatment options.  ...
(Date:5/22/2013)... 22, 2013  Avanir Pharmaceuticals, Inc. (NASDAQ: AVNR ... of the company at the following conferences. , ... date: Wednesday May 29, 2013 , Presentation time: 12:00 ... Conference , Presentation date: Wednesday June 5, 2013 ... A live webcast and 30-day archive of these ...
(Date:5/22/2013)... REHOVOT, Israel , May 22, 2013 ... a leading developer and provider of microRNA-based molecular diagnostics, ... President and Chief Executive Officer of Rosetta Genomics, will ... Conference taking place from June 3-6, 2013 in New ... Tuesday, June 4 th at 2:00 p.m. Eastern ...
Breaking Medicine Technology:Upsher-Smith Successfully Completes Phase III Study Of USL255 (Extended-Release Topiramate) For Adjunctive Treatment Of Epilepsy In Patients With Refractory Partial-Onset Seizures 2Upsher-Smith Successfully Completes Phase III Study Of USL255 (Extended-Release Topiramate) For Adjunctive Treatment Of Epilepsy In Patients With Refractory Partial-Onset Seizures 3Upsher-Smith Successfully Completes Phase III Study Of USL255 (Extended-Release Topiramate) For Adjunctive Treatment Of Epilepsy In Patients With Refractory Partial-Onset Seizures 4Avanir Pharmaceuticals to Participate in Two Upcoming Investor Conferences 2Rosetta Genomics to Present at the Jefferies 2013 Healthcare Conference 2Rosetta Genomics to Present at the Jefferies 2013 Healthcare Conference 3
Cached News: